Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322 2019
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Therefore, this meta-analysis demonstrated that 8q24 polymorphisms (rs6983267 T>G, rs1447295 C>A, rs16901979 C>A, rs6983561 A>C and rs10090154 C>T) were associated with the susceptibility to PCa, which held the potential biomarkers for PCa risk. 29158792 2017
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Overall, though no association was observed between the rs</span>6983267 polymorphism and risk of prostate cancer, subgroup analysis according to ethnicity showed a significant association between the rs6983267 polymorphism and risk of prostate cancer among white European men [recessive model: GG vs TG + TT, OR=1.21, (95% CI: 1.03, 1.42), P=0.02]. 27009866 2016
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056 2015
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Three 8q24 polymorphisms (rs1447295 C>A, rs16901979 C>A, and rs6983267 T>G) have been extensively investigated for their association with prostate cancer (PCa) susceptibility, yet conclusions are contradictory. 26159557 2015
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT Two susceptibility loci identified for prostate cancer aggressiveness. 25939597 2015
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Similarly, in a subgroup analysis of European and Asian descent, our results revealed that there are associations between rs6983267 T/G polymorphism and PCa susceptibility with the dominant model (GG vs GT+TT), recessive model (GG+GT vs TT), and homozygote comparison (GG vs TT). 26782586 2015
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT Genome-wide association scan for variants associated with early-onset prostate cancer. 24740154 2014
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE The polymorphism rs6983267 from region 3 of the chromosome 8q24 appears to be a prominent risk factor for PCa and a biomarker for cancer aggressiveness in the group of patients who presented higher levels of PSA at the time of diagnosis. 24224612 2014
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01). 25315430 2014
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544 2014
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Significant associations were observed for rs4430796 TT with Gleason scores of ≥ 7 (OR = 1.76, 95% CI = 1.14-2.73) and prostate-specific antigen (PSA) levels of ≥ 10 ng/ml at diagnosis (OR = 1.63, 95% CI = 1.01-2.63), as well as for rs6983267 GG with stage 3-4 CaPs (OR = 1.91, 95% CI = 1.01-3.61). 22561070 2013
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE The results of the meta-analyses indicate that rs6983267, rs1447295, rs6983561, rs7837688, rs16901979, and DG8S737 are significantly associated with a higher risk for PCa for at least one race, whereas the variants rs13254738 and rs7000448 are not. 22382457 2012
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE There was a tendency towards significantly increased risk for SNPs rs1447295 and rs6983267 in men with early-onset prostate cancer. 21557270 2011
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE A highly significant association (odds ratio=2.84 and p-value=0.002) was found between rs6983267 and prostate cancer in the Greek population. 22070222 2011
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE We demonstrate that trans-acting RNA molecules facilitating resistance to androgen depletion (RAD) in vitro and castration-resistant phenotype (CRP) in vivo of PC contain intergenic 8q24-locus SNP variants (rs1447295; rs16901979; rs6983267) that were recently linked with increased risk of PC. 22067658 2011
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Correlation between genotypes and biopsy outcome (positive or negative) and Gleason score (≤6 or >6) were studied by univariate and multivariable analysis. rs1447295 and rs6983267 risk variants were found to be associated with the presence of PCa in univariate analysis. rs6983267 genotype remained significantly linked to a positive biopsy (odds ratio [OR] = 1.66, 95% confidence interval [CI]: 1.06-2.59, P = 0.026) in multivariable analysis, but rs1447295 genotype did not (OR = 1.47, 95% CI: 0.89-2.43, P = 0.13).When biopsy outcome was stratified according to Gleason score, risk variants of rs1447295 were associated with aggressive disease (Gleason score ≥7) in univariate and multivariable analysis (OR = 2.05 95% CI: 1.10-3.79, P = 0.023). rs6983267 GG genotype was not related to aggressiveness. 21308149 2011
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE A single nucleotide polymorphism (SNP) rs6983267, located within the 8q24 region, is strongly associated with risk of colorectal and prostate cancer. 19895682 2009
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE The A allele of rs1447295 was significantly associated with the risk of sporadic prostate cancer (p = 0.04; age-adjusted OR, 1.34), while the G allele of rs6983267 showed a trend towards being a high-risk allele (p = 0.06; age-adjusted OR, 1.27). 19602258 2009
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE The highest significance in Caucasian men was found for rs6983267; the AA genotype reduced the risk for PCa [odds ratio (OR) = 0.48, 95% confidence interval (CI) = 0.35-0.65, P = 2.74 x 10(-6)]. 19528667 2009
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls. 19562729 2009
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE The rs6983267 G allele did not show significant association with susceptibility to PC (PC vs. non-PC: P = 0.967; OR, 1.00; 95%CI = 0.83-1.21). 18726982 2008
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE A meta-analysis across 10 studies including our results of four 8q24 variants (rs1442295 and DG8S737-region 1, rs16901979-region 2, and rs6983267-region 3) and prostate cancer risk demonstrated strong associations across a wide array of study designs and populations. 18231127 2008
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation BEFREE Single nucleotide polymorphisms (SNPs) rs6983561 and rs6983267 showed the strongest evidence of prostate cancer association. 18360876 2008
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.800 GeneticVariation GWASCAT Multiple loci identified in a genome-wide association study of prostate cancer. 18264096 2008